Delivery Order SPE2DE24DA010-SPE2D625F3JYL
- Not listed
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a $2,500 delivery order on July 28, 2025, for leadless accessories to support federal healthcare operations. The contract, which carries no set-aside designation and operates under fixed-price pricing with economic price adjustment terms, is funded by the Medical Supply Chain division of the Department of Defense and will be performed in Santa Clara, California. This delivery order represents a continuation of...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $24,350.00 by the Defense Logistics Agency's Medical Supply Chain on September 10, 2025, with an ultimate completion date of September 15, 2025. The contract, which involves no set-aside designation and therefore represents full and open competition, is for the delivery of the Aveir Leadless Pacemaker system to be performed at the contractor's facility in Santa Clara,...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $28,350.00 by the Defense Logistics Agency's Medical Supply Chain on August 18, 2025, with an ultimate completion date of August 21, 2025. The contract, identified as AVEIR (a reference to Abbott's Aveir Leadless Pacemaker technology), will be performed in Santa Clara, California, and was awarded without a set-aside designation, indicating full and open competition. This...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order contract valued at $51.3K by the Medical Supply Chain, a defense-focused federal agency, on July 16, 2025. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of July 21, 2025, and will be performed in Santa Clara, California. The contract was awarded under full and open competition with no set-aside designation, indicating Abbott competed against other...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $8,750 by the Defense Logistics Agency's Medical Supply Chain on August 11, 2025, with an ultimate completion date of August 14, 2025. The contract utilizes a fixed-price pricing structure with economic price adjustment provisions and is not subject to any set-aside designation, indicating full and open competition. The award covers delivery of the AVEIR Leadless Pacemaker to the place...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order contract valued at $1,120.00 by the Medical Supply Chain division of the Department of Defense on September 4, 2025, with an ultimate completion date of September 9, 2025. This fixed-price contract with economic price adjustment authority will be performed in Santa Clara, California. The award represents a continuation of Abbott's extensive role as a critical supplier of advanced cardiovascular...
- Abbott Laboratories Inc.'s Abbott Vascular Inc. division has been awarded a fixed-price delivery order valued at $10,500 by the Medical Supply Chain division of the Department of Defense on September 12, 2025, with an ultimate completion date of September 17, 2025. The contract, which carries no set-aside designation indicating full and open competition, is for the AVEIR leadless pacemaker system and will be performed in Santa Clara, California. This delivery order represents a task order...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order (Contract No. 4568634478, GALLANT) by the Medical Supply Chain division of the Department of Defense on June 20, 2025, with an ultimate completion date of June 25, 2025. The contract, valued at $30,281.95, carries no set-aside designation, indicating full and open competition. Performance will occur at Abbott's facility in Santa Clara, California. This delivery order represents a...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a fixed-price delivery order with economic price adjustment totaling $9,500 by the Defense Logistics Agency's Medical Supply Chain division. The contract, designated as AVEIR and issued on July 29, 2025, with an ultimate completion date of August 1, 2025, will be performed in Santa Clara, California. This delivery order was awarded without set-aside designation, indicating full and open competition among...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $5,495 by the Defense Logistics Agency's Medical Supply Chain on July 30, 2025, with an ultimate completion date of August 4, 2025. This delivery order, which contains no set-aside designation indicating full and open competition, represents a call against a larger indefinite delivery contract vehicle. The work will be performed in Santa Clara, California, and involves the...
- SPE2DE24DA010Indefinite Delivery Contract
- SPE2DE24DA010-SPE2D625F3JYLDelivery Order
Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a $2,000 delivery order for leadless accessories by the Medical Supply Chain division of the Department of Defense on September 12, 2025, with an ultimate completion date of September 17, 2025. The contract is a fixed-price delivery order with economic price adjustment provisions and was awarded without a set-aside designation, indicating full and open competition. Performance will take place in Santa Clara, California. This delivery order represents a continuation of Abbott Vascular's established relationship with federal defense medical supply procurement. Abbott Vascular has secured substantial contract vehicles with the Defense Logistics Agency, including a $117.1 million indefinite delivery contract for cardiovascular procedural packages. The leadless accessories being procured under this order align with Abbott's portfolio of advanced cardiovascular technologies, particularly supporting the company's leadless pacemaker products such as the Aveir system that have been supplied to federal healthcare systems. The relatively modest ceiling value of this delivery order suggests it addresses a specific, near-term requirement within the broader federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 9/12/25 |